XML 49 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Information
12 Months Ended
Dec. 31, 2018
Segment Reporting, Measurement Disclosures [Abstract]  
Segment Information
SEGMENT INFORMATION
The Company operates and reports its results in four separate business segments consisting of the Life Sciences, Diagnostics, Dental and Environmental & Applied Solutions segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income and expense, interest and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. The identifiable assets by segment are those used in each segment’s operations. Intersegment amounts are not significant and are eliminated to arrive at consolidated totals.
Detailed segment data for the years ended December 31 is as follows ($ in millions):
 
2018
 
2017
 
2016
Sales:
 
 
 
 
 
Life Sciences
$
6,471.4

 
$
5,710.1

 
$
5,365.9

Diagnostics
6,257.6

 
5,839.9

 
5,038.3

Dental
2,844.5

 
2,810.9

 
2,785.4

Environmental & Applied Solutions
4,319.5

 
3,968.8

 
3,692.8

Total
$
19,893.0

 
$
18,329.7

 
$
16,882.4

 
 
 
 
 
 
Operating profit:
 
 
 
 
 
Life Sciences
$
1,229.3

 
$
1,004.3

 
$
818.9

Diagnostics
1,073.8

 
871.6

 
786.4

Dental
346.7

 
400.7

 
419.4

Environmental & Applied Solutions
988.0

 
914.6

 
870.0

Other
(234.0
)
 
(200.8
)
 
(159.5
)
Total
$
3,403.8

 
$
2,990.4

 
$
2,735.2

 
 
 
 
 
 
Identifiable assets:
 
 
 
 
 
Life Sciences
$
22,122.4

 
$
20,576.8

 
$
19,875.9

Diagnostics
14,031.1

 
14,359.2

 
14,159.6

Dental
5,897.3

 
6,026.8

 
5,772.2

Environmental & Applied Solutions
4,637.3

 
4,649.2

 
4,172.9

Other
1,144.4

 
1,036.6

 
1,314.7

Total
$
47,832.5

 
$
46,648.6

 
$
45,295.3

 
 
 
 
 
 
Depreciation and amortization:
 
 
 
 
 
Life Sciences
$
471.2

 
$
427.9

 
$
426.2

Diagnostics
589.0

 
581.5

 
481.5

Dental
130.0

 
121.4

 
127.2

Environmental & Applied Solutions
109.0

 
99.9

 
86.7

Other
8.5

 
7.6

 
6.5

Total
$
1,307.7

 
$
1,238.3

 
$
1,128.1

 
2018
 
2017
 
2016
Capital expenditures, gross:
 
 
 
 
 
Life Sciences
$
140.1

 
$
130.6

 
$
109.7

Diagnostics
380.0

 
372.6

 
374.3

Dental
72.2

 
48.9

 
49.1

Environmental & Applied Solutions
57.1

 
60.9

 
51.0

Other
6.3

 
6.6

 
5.5

Total
$
655.7

 
$
619.6

 
$
589.6


Operations in Geographical Areas:
 
Year Ended December 31
($ in millions)
2018
 
2017
 
2016
Sales:
 
 
 
 
 
United States
$
7,374.4

 
$
6,837.9

 
$
6,377.4

China
2,357.3

 
2,011.6

 
1,799.1

Germany
1,247.0

 
1,161.6

 
1,084.6

Japan
918.7

 
872.1

 
864.7

All other (each country individually less than 5% of total sales)
7,995.6

 
7,446.5

 
6,756.6

Total
$
19,893.0

 
$
18,329.7

 
$
16,882.4

 
 
 
 
 
 
Property, plant and equipment, net:
 
 
 
 
 
United States
$
1,224.4

 
$
1,126.2

 
$
1,198.4

Germany
198.3

 
212.4

 
190.8

United Kingdom
157.0

 
152.0

 
140.6

All other (each country individually less than 5% of total property, plant and equipment, net)
931.5

 
964.0

 
824.2

Total
$
2,511.2

 
$
2,454.6

 
$
2,354.0


Sales by Major Product Group:
 
Year Ended December 31
($ in millions)
2018
 
2017
 
2016
Analytical and physical instrumentation
$
2,437.0

 
$
2,232.9

 
$
2,088.9

Research and medical products
12,686.0

 
11,512.4

 
10,366.7

Dental products
2,844.5

 
2,810.9

 
2,785.4

Product identification
1,925.5

 
1,773.5

 
1,641.4

Total
$
19,893.0

 
$
18,329.7

 
$
16,882.4